10-Q quarterly report · filed Oct 30, 2026

Stryker Corporation (SYK) Q3 2026 10-Q Quarterly Report

Short answer

Stryker Corporation (SYK) filed its Q3 2026 10-Q quarterly report on Oct 30, 2026 for the quarter ended Sep 30, 2026. Quarterly revenue was $6.5B (up 7.6% year over year) with net income of $753M.

Q3 2026 key financials · XBRL

Revenue
$6.5B
+7.6% YoY · −1.0% QoQ
Net income
$753M
−12.3% YoY · −41.0% QoQ
Operating margin
15.9%
Gross margin
65.2%
EPS (diluted)
$1.96
−11.7% YoY · −40.6% QoQ

Source: XBRL data from the Stryker Corporation (SYK) Q3 2026 10-Q on SEC EDGAR. USD.

Stryker Corporation Q3 2026 10-Q analysis

AI summary of MD&A and risk factor updates

Management Discussion & Analysis

  • Revenue $6,520M, up 7.7% YoY from $6,057M, driven by increased unit volume
  • Operating margin 15.9% vs 18.7% YoY, adjusted margin 26.2% vs 25.6%
  • Best segment: MedSurg and Neurotechnology sales up 9.2%, margin 28.7% vs 26.1%
  • Worst segment: Orthopaedics sales up 5.7%, margin 31.2% vs 32.4%
  • Operating cash flow $3,303M vs $2,901M; $1,000M debt repayment, $1,000M share repurchases, dividends
  • Peripheral Vascular supply constraints and slower recovery triggered a $293M goodwill impairment charge

Risk Factors

  • No material changes to 2025 Form 10-K risk factors
  • No material changes from March 31, 2026 Form 10-Q risk factors

Generated from the filing text; verify against the original. 10-K vs 10-Q vs 8-K

Other Stryker Corporation quarterly reports

Ask about this quarter

Compare quarters, check guidance or see what insiders and funds did around the report.